You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is the best buy from here? ⊕

found 2025 › Nov › 24 (Mon) @ 18:10 UTC

Eli Lilly's stock is soaring while Novo Nordisk is sinking. Why it makes sense to stick with the market winner, despite its rising valuation.